Conference poster

The orally available sodium/taurocholate co-transporting polypeptide inhibitor A2342 blocks hepatitus B and D entry in vitro


Authors listBonn, B; Strängberg, E; Uzelac, I; Kirstgen, M; Goldmann, N; Glebe, D; Geyer, J; Lindström, E

Publication year2022

PagesS843-S843

JournalJournal of Hepatology

Volume number77

ISSN0168-8278

eISSN1600-0641

DOI Linkhttps://doi.org/10.1016/S0168-8278(22)01982-1

ConferenceInternational Liver Congress 2022

PublisherElsevier



Citation Styles

Harvard Citation styleBonn, B., Strängberg, E., Uzelac, I., Kirstgen, M., Goldmann, N., Glebe, D., et al. (2022) The orally available sodium/taurocholate co-transporting polypeptide inhibitor A2342 blocks hepatitus B and D entry in vitro [Poster], Journal of Hepatology, 77, p. S843. https://doi.org/10.1016/S0168-8278(22)01982-1

APA Citation styleBonn, B., Strängberg, E., Uzelac, I., Kirstgen, M., Goldmann, N., Glebe, D., Geyer, J., & Lindström, E. (2022). The orally available sodium/taurocholate co-transporting polypeptide inhibitor A2342 blocks hepatitus B and D entry in vitro. Journal of Hepatology. 77, S843. https://doi.org/10.1016/S0168-8278(22)01982-1


Last updated on 2025-21-05 at 16:48